ClinicalTrials.Veeva

Menu

Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF

I

IVI Vigo

Status

Completed

Conditions

Ectopic Pregnancy

Treatments

Other: Analysis of Ectopic Pregnancy incidence

Study type

Observational

Funder types

Other

Identifiers

NCT02793089
1409-VGO-059-EM

Details and patient eligibility

About

This study evaluates the increased risk of ectopic pregnancy associated with marked variation of estradiol during the early luteal phase and high progesterone on hCG day in IVF.

Full description

This is a retrospective cohort study of 578 patients who had no risk of EP (672 fresh transfer IVF cycles) between January 2005 and December 2014. Few studies have reported the relation between hormonal levels and ectopic pregnancy (EP) in IVF. Investigators describe EP incidence according to estradiol (E2) and progesterone (P4) levels on hCG day and seven days later (hCG+7) or their variation between both days.

Enrollment

578 patients

Sex

Female

Ages

25 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Normal Fallopian tubes in HSG and /or laparoscopy
  • Normal Uterus: Abscence of myomas and Müllerian anomalies .

Exclusion criteria

  • Previous Ectopic Pregnancy .
  • Recurrent Abortion .
  • Tubal Factor : pelvic inflammatory disease, Hydrosalpinx
  • Previous abdominal surgery (except laparoscopy) .
  • Prior Peritonitis
  • Smoking (at least 1 cigarette/day) .

Trial design

578 participants in 4 patient groups

First quartile
Description:
No drugs are administered. It is an observational study. Collect retrospectively data.Analysis of Ectopic Pregnancy incidence through Estradiol (E2) and progesterone (P4) levels on hCG day and seven days later (hCG+7).
Treatment:
Other: Analysis of Ectopic Pregnancy incidence
Second quartile
Description:
No drugs are administered. It is an observational study. Collect retrospectively data.Analysis of Ectopic Pregnancy incidence through Estradiol (E2) and progesterone (P4) levels on hCG day and seven days later (hCG+7).
Treatment:
Other: Analysis of Ectopic Pregnancy incidence
Third quartile
Description:
No drugs are administered. It is an observational study. Collect retrospectively data.Analysis of Ectopic Pregnancy incidence through Estradiol (E2) and progesterone (P4) levels on hCG day and seven days later (hCG+7)
Treatment:
Other: Analysis of Ectopic Pregnancy incidence
Fourth quartile
Description:
No drugs are administered. It is an observational study. Collect retrospectively data.Analysis of Ectopic Pregnancy incidence through Estradiol (E2) and progesterone (P4) levels on hCG day and seven days later (hCG+7)
Treatment:
Other: Analysis of Ectopic Pregnancy incidence

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems